How Qualcomm Licensed Chip Designs to Chinese OEMs: Semiconductor Case Study
Qualcomm Incorporated, the San Diego-based fabless semiconductor giant, has built one of the most successful technology licensing businesses in history — and nowhere has that model been more consequential than in China. With Chinese original equipment manufacturers (OEMs) producing the vast majority of the world’s smartphones and an ever-growing share of IoT, automotive, and networking devices, Qualcomm’s patent licensing and chipset supply relationships with Chinese OEMs have shaped both the company’s fortunes and the trajectory of China’s mobile ecosystem. This case study examines how Qualcomm structured its licensing arrangements with Chinese OEMs, navigated China’s antitrust environment, and adapted its strategy as geopolitical tensions reshaped the semiconductor landscape through 2026.
Background: Qualcomm’s Licensing Business Model and China Market Ambitions
Qualcomm’s business model rests on two complementary pillars: its QCT (Qualcomm CDMA Technologies) semiconductor division, which designs and sells Snapdragon and other chipset platforms, and its QTL (Qualcomm Technology Licensing) division, which licenses the company’s vast portfolio of standard-essential patents (SEPs) covering cellular communications standards including 3G (CDMA2000, WCDMA, TD-SCDMA), 4G/LTE, and 5G NR. This dual-revenue structure has generated extraordinary margins: in fiscal 2025, QTL contributed approximately $7.3 billion in pre-tax earnings on relatively low operating costs, with licensing revenue margins exceeding 70 percent.
China has been central to Qualcomm’s licensing strategy for two decades. According to the Semiconductor Industry Association (SIA), China accounted for approximately 35 percent of global semiconductor consumption in 2025. Within that, Chinese smartphone OEMs — including Xiaomi, Oppo, Vivo, Honor, and former licensee Huawei (before its own chip design capabilities were curtailed by US sanctions) — collectively purchase tens of millions of Snapdragon chipsets annually and license Qualcomm’s patent portfolio for every device they sell that connects to cellular networks. At its peak in 2024, Qualcomm derived roughly 60 percent of its total revenue from the Chinese market, including both chip sales and licensing fees.
The foundational challenge for Qualcomm in China has been securing licensing agreements that reflect its patent portfolio’s value while operating within the pricing constraints and regulatory environment of the world’s largest mobile handset market. Chinese OEMs, many operating on thin single-digit margins, have consistently pushed back on royalty rates, creating a dynamic of periodic negotiation, regulatory intervention, and rebalancing that has defined Qualcomm’s China licensing strategy.
China’s Antitrust Regime and the NDRC Investigation
The defining regulatory event for Qualcomm’s China licensing model was the National Development and Reform Commission (NDRC) antitrust investigation that concluded in February 2015. The NDRC, after a 14-month investigation triggered by complaints from Chinese OEMs and the company’s dominant position in baseband chipsets, found that Qualcomm had abused its market dominance by:
- Charging unfairly high patent licensing fees, calculated as a percentage of the entire device price rather than the value of the patented technology alone
- Requiring licensees to grant back cross-licenses on a royalty-free basis as a condition for obtaining Qualcomm’s patent license
- Tying the sale of baseband chips to patent licensing, forcing chip customers to accept patent license terms they might otherwise negotiate separately
The NDRC imposed a record fine of 6.088 billion yuan (approximately $975 million at the time) — the largest antitrust penalty in Chinese history. More significantly, the regulator mandated structural changes to Qualcomm’s licensing model: the company was required to offer separate patent licenses for its 3G and 4G essential patents, calculate royalty rates as a percentage of the net selling price of devices (capped at 65 percent of the device’s wholesale price), and abandon its practice of demanding free cross-licenses. The agreed royalty rates — 5 percent for 3G devices and 3.5 percent for 4G devices — represented a meaningful concession from Qualcomm’s prior pricing.
| Dimension | Pre-NDRC Settlement | Post-NDRC Settlement |
|---|---|---|
| Royalty base | Full device wholesale price | 65% of net selling price |
| 3G rate | 5.0–6.0% of full device price | 5.0% of net selling price (effectively 3.25%) |
| 4G rate | 5.0–6.0% of full device price | 3.5% of net selling price (effectively 2.275%) |
| Cross-license grant-back | Mandatory, royalty-free | Negotiated per agreement |
| Chip-tying provisions | Required with patent license | Separated — chips negotiated independently |
For Chinese OEMs, this settlement was transformative. Xiaomi, Oppo, Vivo, and other major handset makers signed new license agreements that lowered their effective royalty burden by approximately 40 percent compared to pre-2015 terms. Qualcomm, for its part, accepted the structural changes as the price of continued access to the Chinese market, which was then generating over half of its licensing revenue.
Navigating the Post-Settlement Landscape: Qualcomm’s China Licensing Strategy
In the decade following the NDRC settlement, Qualcomm pursued a multi-layered licensing strategy designed to maximize royalty revenue within the new regulatory constraints while deepening chipset sales relationships with Chinese OEMs. The strategy unfolded along several tracks:
Patent portfolio renewal and 5G licensing. As 5G networks were deployed globally from 2019 onward, Qualcomm negotiated new 5G licensing terms with Chinese OEMs. The company secured 5G royalty rates of 3.125 percent for devices using only 5G (with a $400 per-device cap) and 5 percent for multi-mode devices, effectively maintaining the economic value of its licensing business as the industry transitioned from 4G. Chinese OEMs, facing a standard-essential patent landscape where Qualcomm held approximately 15 percent of all 5G SEPs, had limited alternatives and largely accepted these terms.
OEM-by-OEM negotiations. Rather than offering uniform terms, Qualcomm negotiated individual licensing agreements with each major Chinese OEM. This allowed the company to calibrate royalty rates based on each OEM’s patent portfolio, device mix, and negotiating leverage. Oppo, which built a substantial patent portfolio of its own, secured relatively favorable terms in part through a cross-license of its own intellectual property. Smaller OEMs with limited patent assets paid higher effective rates.
Deepening chipset partnerships. Qualcomm used its Snapdragon chipset roadmap to strengthen relationships with Chinese OEMs, offering early access to reference designs, engineering support, and co-marketing opportunities to OEMs that maintained licensing compliance. This “chips-for-licensing” ecosystem created switching costs for OEMs considering alternative chipset suppliers such as MediaTek or UNISOC.
Joint ventures and local R&D. Qualcomm established joint ventures with Chinese companies including a 2016 partnership with Guizhou Province to develop advanced server chips (the Guizhou Hua Xin Tong IC Design joint venture) and continued collaboration with SMIC and IMEC through the SMIC Advanced Technology R&D center in Shanghai. These investments signaled Qualcomm’s commitment to the Chinese market and strengthened its negotiating position in licensing discussions.
Key Challenges and Mitigation
Regulatory risk and antitrust uncertainty. The most persistent challenge has been China’s evolving antitrust enforcement. Following the 2015 NDRC settlement, China’s antitrust authorities — now unified under the State Administration for Market Regulation (SAMR) — continued to scrutinize standard-essential patent licensing practices. In 2022, SAMR announced guidelines on SEP licensing in the Internet of Things (IoT) sector, adding uncertainty for Qualcomm’s expansion into non-handset licensing. Qualcomm mitigated this by proactively engaging SAMR on the economic rationale for its royalty model and by complying with China’s evolving SEP disclosure and FRAND (fair, reasonable, and non-discriminatory) requirements.
Geopolitical headwinds and US export controls. Beginning with the October 2022 US export controls on advanced semiconductor technology to China, Qualcomm faced a challenging dual role: a US-headquartered company supplying critical chips to Chinese customers under intensifying US government restrictions. The 2022 controls restricted the export of advanced computing and AI chips but left Qualcomm’s smartphone chipset business largely unaffected. However, in mid-2025, the US Commerce Department expanded restrictions on AI-capable chips to Thailand and Malaysia, and in 2026 approved selectively licensed NVIDIA H200 sales to Chinese companies — a signal of potential stabilization that Qualcomm leveraged in its licensing discussions.
Patent non-payment by recalcitrant OEMs. Certain Chinese OEMs at times withheld licensing payments to gain negotiating leverage. In 2017, Apple — which sources iPhones from Chinese contract manufacturers Foxconn and Pegatron — directed its contract manufacturers in China to stop paying Qualcomm royalties, triggering a global legal battle only resolved with a settlement and $4.5 billion payment in 2019. For Chinese OEMs, Qualcomm employed a combination of legal pressure (breach-of-contract claims in Chinese courts), chipset supply leverage, and negotiated payment plans to resolve non-payment situations.
Competition from in-house chip design. Huawei’s HiSilicon division was an early leader in China-based chip design, but US sanctions after 2019 eliminated HiSilicon’s access to advanced foundry services. Xiaomi, Oppo, and Vivo all explored in-house chip design as a long-term alternative to Qualcomm. Xiaomi’s Surge processor line and Oppo’s MariSilicon NPU demonstrated capability in specialized areas but lacked the comprehensive baseband-processor integration that makes Snapdragon difficult to replace. Qualcomm mitigated this by maintaining a ~12–18 month technology lead in modem-processor integration and by offering Chinese OEMs access to its latest architecture on favorable terms.
Lessons for Foreign Investors
- Understand that China’s antitrust remedies are structural, not punitive. The 2015 NDRC settlement changed Qualcomm’s licensing model permanently — royalty rates, calculation bases, and grant-back terms all shifted. Foreign technology licensors entering China must plan for the possibility that their global pricing model will not survive Chinese regulatory scrutiny and that structural concessions may be required to access the market at scale.
- Build China-specific regulatory expertise early. Qualcomm’s decade-long investment in understanding China’s antitrust regime, building relationships with NDRC and later SAMR officials, and proactively engaging on policy development gave the company far better outcomes than it would have achieved through litigation alone. Foreign firms should establish dedicated China regulatory affairs teams before scaling market entry.
- Local partnerships signal commitment. Qualcomm’s joint ventures with Guizhou Province, SMIC, and other Chinese entities served as tangible proof of its commitment to China’s semiconductor ecosystem. These partnerships were referenced in regulatory negotiations as evidence of mutual benefit, helping to offset perceptions of the company as an extractive licensor.
- Chipset-licensing bundling must be managed carefully. The NDRC’s prohibition on tying chip sales to patent licenses changed Qualcomm’s distribution strategy. Foreign firms with similar dual-revenue models should design their licensing and product structures to withstand antitrust scrutiny on both dimensions, or be prepared to separate them on short notice.
- Geopolitical risk requires contingency planning. Qualcomm’s exposure to US-China semiconductor tensions has grown with each export control expansion since 2022. Foreign semiconductor companies operating in China should model multiple scenarios — from full decoupling to managed trade — and maintain supply chain flexibility that allows serving both markets under divergent regulatory regimes.
Where to Go From Here
Qualcomm’s China licensing strategy demonstrates that even the most powerful patent portfolios must adapt to local regulatory realities. Foreign semiconductor firms entering or expanding in China should understand both the licensing opportunity and the antitrust frameworks that govern it.
- Ready to act? Read [guide: SLUG-TO-BE-FILLED]
- Still comparing? See [comparison: SLUG-TO-BE-FILLED]
- Need numbers? Try [tool: SLUG-TO-BE-FILLED]
How Qualcomm Licensed Chip Designs to Chinese OEMs: Semiconductor Case Study — first published on China Gateway 360. Last updated: July 2026.
